Combining Surgery and Biologic Therapy Improves Outcomes in Patients With CRSwNP
August 26th 2023Combination endoscopic sinus surgery (ESS) and biological therapy significantly decreased polyp burden in refractory chronic rhinosinusitis with nasal polyposis (CRSwNP) compared with biologic therapy alone
Read More
Catherine Nester Discusses the BeginNGS Tool for Newborn Rare Disease Screening Awareness
August 25th 2023Catherine Nester, RN, vice president of physician and patient strategies at Inozyme Pharma, highlights the importance of newborn screening for rare diseases and the impact of the BeginNGS diagnostic tool.
Watch
Second-Line Axi-Cel Produces Complete Metabolic Responses in Transplant-Ineligible LBCL
August 24th 2023Second-line treatment with axicabtagene ciloleucel (axi-cel) led to an investigator-assessed, 3-month complete metabolic response rate of 71.0% in patients with large B-cell lymphoma (LBCL) who were ineligible for autologous stem cell transplant.
Read More
Neighborhood Opportunities Linked to Child Well-Being in Primary Care
August 24th 2023Results reveal living in neighborhoods with very high Childhood Opportunity Index (COI) scores is linked with elevated odds of being up to date on preventive visits and immunizations when compared with those living in neighborhoods with very low COI scores.
Read More
Patients and physicians are publicly shaming insurance companies on social media for the troublesome prior authorization process; HHS has awarded $1.4 billion in grants for the creation of new technologies and tools to prevent COVID-19 infection; Novo Nordisk has increased lobbying efforts to allow Medicare coverage of weight loss drugs.
Read More